Filing Details
- Accession Number:
- 0001225208-21-014512
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-06 17:18:50
- Reporting Period:
- 2021-12-03
- Accepted Time:
- 2021-12-06 17:18:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1594762 | A Rady Johnson | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-12-03 | 200 | $53.47 | 74,644 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 300 | $53.51 | 74,344 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 371 | $53.37 | 73,973 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 400 | $53.41 | 73,573 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 500 | $53.42 | 73,073 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 1,200 | $53.49 | 71,873 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 2,200 | $53.46 | 69,673 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 2,719 | $53.50 | 66,954 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 2,756 | $53.40 | 64,198 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 3,627 | $53.38 | 60,571 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 4,727 | $53.39 | 55,844 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,714 | Indirect | By Rule 16b-3 Plan |
Billionaire Hedge Funds
